152 related articles for article (PubMed ID: 22127362)
61. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
[TBL] [Abstract][Full Text] [Related]
62. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
63. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma.
Mancuso S; Smaniotto D; Benedetti Panici P; Favale B; Greggi S; Manfredi R; Margariti PA; Morganti AG; Scambia G; Tortoreto F; Valentini V; Cellini N
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):324-8. PubMed ID: 10985888
[TBL] [Abstract][Full Text] [Related]
64. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
65. Weekly cisplatin 20 mg/m2 in patients with carcinoma of cervix receiving pelvic radiotherapy at Srinagarind Hospital: a randomized controlled trial.
Punushapai U; Yuenyao P; Chumworathayi B; Luanratanakorn S; Udomthavornsuk B
Asian Pac J Cancer Prev; 2010; 11(1):201-7. PubMed ID: 20593957
[TBL] [Abstract][Full Text] [Related]
66. Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.
Uno T; Mitsuhashi A; Isobe K; Yamamoto S; Kawakami H; Ueno N; Usui H; Tate S; Kawata T; Ito H
Int J Gynecol Cancer; 2008; 18(1):80-4. PubMed ID: 17466053
[TBL] [Abstract][Full Text] [Related]
67. [Laparoscopic management of occult cervical cancer discovered after simple hysterectomy].
Vignancour S; Narducci F; Collinet P; Vinatier D; Castelain B; Leblanc E
Gynecol Obstet Fertil; 2007 Apr; 35(4):297-302. PubMed ID: 17337353
[TBL] [Abstract][Full Text] [Related]
68. Total Laparoscopic Resection Surgery for a Cervical Carcinoma that Recurred in the Pelvic Sidewall After Radical Hysterectomy and Adjuvant Concurrent Chemoradiotherapy.
Kanao H; Aoki Y; Kato K; Matoda M; Okamoto S; Nomura H; Omatsu K; Utsugi K; Takeshima N
J Minim Invasive Gynecol; 2017; 24(6):899-900. PubMed ID: 28642025
[TBL] [Abstract][Full Text] [Related]
69. Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin.
Ikushima H; Osaki K; Furutani S; Yamashita K; Kawanaka T; Kishida Y; Iwamoto S; Takegawa Y; Kudoh T; Nishitani H
Radiat Med; 2006 Feb; 24(2):115-21. PubMed ID: 16715672
[TBL] [Abstract][Full Text] [Related]
70. Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer.
Miyauchi R; Itoh Y; Kawamura M; Hirakawa A; Shibata K; Kajiyama H; Nakahara R; Kubota S; Ito J; Okada T; Kikkawa F; Naganawa S
Nagoya J Med Sci; 2017 Feb; 79(2):211-220. PubMed ID: 28626256
[TBL] [Abstract][Full Text] [Related]
71. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
72. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH
Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204
[TBL] [Abstract][Full Text] [Related]
73. Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer.
Martínez-Monge R; Jurado M; Aristu JJ; Moreno M; Cambeiro M; Pérez-Ochoa A; López-García G; Alcazar JL
Gynecol Oncol; 2001 Sep; 82(3):538-43. PubMed ID: 11520152
[TBL] [Abstract][Full Text] [Related]
74. Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer.
Murata S; Onozawa S; Sugihara F; Sakamoto A; Ueda T; Yamaguchi H; Yasui D; Mine T; Kumita S
Ann Surg Oncol; 2015 Nov; 22(12):3981-9. PubMed ID: 25758191
[TBL] [Abstract][Full Text] [Related]
75. [Adjuvant simultaneous radiochemotherapy after operated uterine cervix carcinoma in high risk situation. Results of a pilot study].
Hänsgen G; Kuhnt T; Pigorsch S; Strauss H; Dunst J
Strahlenther Onkol; 2002 Feb; 178(2):71-7. PubMed ID: 11942040
[TBL] [Abstract][Full Text] [Related]
76. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma].
Nöel G; Mazeron JJ
Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699
[No Abstract] [Full Text] [Related]
77. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
[TBL] [Abstract][Full Text] [Related]
78. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
Chen SW; Liang JA; Yang SN; Lin FJ
Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
[TBL] [Abstract][Full Text] [Related]
79. Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
Bae HS; Kim YJ; Lim MC; Seo SS; Park SY; Kang S; Kim SH; Kim JY
Int J Gynecol Cancer; 2016 May; 26(4):737-42. PubMed ID: 26937749
[TBL] [Abstract][Full Text] [Related]
80. Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases.
Mabuchi S; Okazawa M; Isohashi F; Ohta Y; Maruoka S; Yoshioka Y; Enomoto T; Morishige K; Kamiura S; Kimura T
Gynecol Oncol; 2011 Jan; 120(1):94-100. PubMed ID: 20956013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
